Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | RAB9A | P51151 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.50 |
| ▸ | ELANE | P08246 | 2/20 | 0.49 |
| ▸ | IDH1 | O75874 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | HNF4A | P41235 | 1/20 | 0.46 |
| ▸ | TTR | P02766 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21811333 | 0.98 | MAPK1 (0.63) | MAPK1NPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL10883168 | 0.96 | MAPK1 (0.61) | MAPK1NPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL16265473 | 0.96 | LMNA (0.55) | MAPK1NPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL21840832 | 0.92 | NPC1 (0.56) | MAPK1NPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL9642148 | 0.89 | IDO1 (0.52) | MAPK1NPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL9644120 | 0.86 | ALDH1A1 (0.55) | MAPK1NPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL10525358 | 0.83 | PARP11 (0.44) | MAPK1NPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL27772234 | 0.82 | NPC1 (0.63) | MAPK1NPC1ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL889584 | 0.80 | ALOX15 (0.48) | ALDH1A1LMNAPARP11CALM1ELANE | |
| SCHEMBL9627609 | 0.79 | PTPN1 (0.45) | MAPK1NPC1ALDH1A1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6723870-B2 | REACTING A METAL HYDRIDE WITH AN ANTHRAQUINONE, DEKETALIZATION; DYE INTERMEDIATES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-04-20 | — | — | US | disclosed |
| US-20030069443-A1 | Method for producing anthracenes | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069443-A1 | Method for producing anthracenes | AKR7A2, ADH1A, CYP2E1 | MAPK1 3481/4885NPC1 2264/4885ALDH1A1 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.